SCHEMBL5793271

SCHEMBL5793271

Cc1nn(C)c(C)c1CN(Cc1ccc2[nH]c(CN3CCCC3)cc2c1)C1CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
MAPK1 P28482 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KDM4E B2RXH2 6/20 0.43
POLB P06746 1/20 0.43
PKM P14618 1/20 0.43
HRH4 Q9H3N8 1/20 0.39
HRH3 Q9Y5N1 2/20 0.36
DRD2 P14416 2/20 0.35
DRD3 P35462 2/20 0.35
ALDH1A1 P00352 5/20 0.35
TSHR P16473 3/20 0.35
ALOX15 P16050 2/20 0.35
MAPT P10636 2/20 0.35
HSD17B10 Q99714 2/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
USP2 O75604 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5823581 0.85 KDM4E (0.41) MEN1KMT2ASMN1; SMN2KDM4EHRH4
SCHEMBL5823556 0.73 HRH4 (0.41) HRH4HRH3DRD2DRD3CHEK1
SCHEMBL5785904 0.72 HRH3 (0.43) MEN1KMT2AMAPK1SMN1; SMN2KDM4E
SCHEMBL5785907 0.72 HRH3 (0.43) MEN1KMT2AMAPK1SMN1; SMN2KDM4E
SCHEMBL5824293 0.72 HRH4 (0.37) HRH4HRH3DRD2DRD3CHEK1
SCHEMBL5917599 0.71 CHEK1 (0.52) SMN1; SMN2KDM4EPOLBHRH4HRH3
SCHEMBL5793366 0.70 HRH4 (0.42) HRH4HRH3DRD2DRD3CHEK1
SCHEMBL5796234 0.70 HRH4 (0.42) HRH4HRH3DRD2DRD3ALDH1A1
SCHEMBL5796265 0.69 HRH4 (0.46) MEN1KMT2AHRH4HRH3DRD2
SCHEMBL5793998 0.68 HRH4 (0.42) MEN1KMT2AMAPK1HRH4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006035308-A1 HISTAMINE-3 RECEPTOR ANTAGONISTS PFIZER PRODUCTS INC. (US) 2006-04-06 WO claimed
US-20060069087-A1 Histamine-3 receptor antagonists PFIZER INC 2006-03-30 US claimed
WO-2006035308-A1 HISTAMINE-3 RECEPTOR ANTAGONISTS PFIZER PRODUCTS INC. (US) 2006-04-06 WO disclosed
US-20060069087-A1 Histamine-3 receptor antagonists PFIZER INC 2006-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069087-A1 Histamine-3 receptor antagonists HRH3, HRH4, HRH2 MEN1 2964/4885KMT2A 1130/4885MAPK1 3228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.